In 40 years of activity, the Italian Amyotrophic Lateral Sclerosis Association (AISLA) has succeeded in transforming hope into possibility. The confirmation comes from the two milestones of historic importance achieved right around the birthday of Aisla and the whole community of people with amyotrophic lateral sclerosis (ALS): the approval of the new INPS guidelines and the drug Tofersen.